MXPA03009057A - Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad. - Google Patents

Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad.

Info

Publication number
MXPA03009057A
MXPA03009057A MXPA03009057A MXPA03009057A MXPA03009057A MX PA03009057 A MXPA03009057 A MX PA03009057A MX PA03009057 A MXPA03009057 A MX PA03009057A MX PA03009057 A MXPA03009057 A MX PA03009057A MX PA03009057 A MXPA03009057 A MX PA03009057A
Authority
MX
Mexico
Prior art keywords
anxiety
beta
pharmaceutical use
use against
carboline derivatives
Prior art date
Application number
MXPA03009057A
Other languages
English (en)
Inventor
Thomas J Troxler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MXPA03009057A publication Critical patent/MXPA03009057A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MXPA03009057A 2001-04-03 2002-04-02 Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad. MXPA03009057A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108337.7A GB0108337D0 (en) 2001-04-03 2001-04-03 Organic compounds
PCT/EP2002/003624 WO2002081471A1 (en) 2001-04-03 2002-04-02 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety

Publications (1)

Publication Number Publication Date
MXPA03009057A true MXPA03009057A (es) 2004-02-12

Family

ID=9912165

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009057A MXPA03009057A (es) 2001-04-03 2002-04-02 Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad.

Country Status (27)

Country Link
US (1) US6861430B2 (es)
EP (1) EP1377578B1 (es)
JP (1) JP4405732B2 (es)
KR (1) KR100564840B1 (es)
CN (1) CN1309721C (es)
AR (1) AR035451A1 (es)
AT (1) ATE517104T1 (es)
AU (1) AU2002316828B2 (es)
BR (1) BR0208566B1 (es)
CA (1) CA2440014C (es)
CZ (1) CZ295992B6 (es)
EC (1) ECSP034754A (es)
ES (1) ES2368389T3 (es)
GB (1) GB0108337D0 (es)
HU (1) HUP0400317A3 (es)
IL (1) IL157545A0 (es)
MX (1) MXPA03009057A (es)
MY (1) MY134026A (es)
NO (1) NO20034413D0 (es)
NZ (1) NZ528370A (es)
PE (1) PE20021018A1 (es)
PL (1) PL210861B1 (es)
PT (1) PT1377578E (es)
RU (1) RU2003130644A (es)
SK (1) SK12222003A3 (es)
WO (1) WO2002081471A1 (es)
ZA (1) ZA200306108B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
JP4671123B2 (ja) 2003-06-23 2011-04-13 小野薬品工業株式会社 新規三環性複素環化合物
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
JP4997976B2 (ja) 2004-12-22 2012-08-15 小野薬品工業株式会社 三環式化合物およびその用途
US7879859B2 (en) 2005-11-21 2011-02-01 Merck Sharp & Dohme Corp. Diagnosis and treatment of type 2 diabetes and other disorders
US20070149557A1 (en) * 2005-11-21 2007-06-28 Amgen Inc. CXCR3 antagonists
CA2693214A1 (en) * 2007-07-19 2009-01-22 Merck Sharp & Dohme Corp. Beta carboline derivatives as antidiabetic compounds
WO2009016329A1 (en) * 2007-07-31 2009-02-05 Cambridge Enterprise Limited Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions
WO2009155388A1 (en) 2008-06-20 2009-12-23 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
BRPI0922057A2 (pt) 2008-11-19 2015-12-15 Envivo Pharmaceuticals Inc tratamento dos transtorno cognitivos com (r)-7-cloro-n-(quiniclidin-3-il)benzo[b]tiofeno-2-carboxamida e sais farmeceuticamente aceitaveis do mesmo
TW201028414A (en) 2009-01-16 2010-08-01 Merck Sharp & Dohme Oxadiazole beta carboline derivatives as antidiabetic compounds
JP2013517272A (ja) 2010-01-15 2013-05-16 メルク・シャープ・エンド・ドーム・コーポレイション 抗糖尿病化合物としてのオキサジアゾール・ベータ・カルボリン誘導体
UY33389A (es) 2010-05-17 2011-12-30 Mitsubishi Tanabe Pharma Corp Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidrato
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции
CN111349096B (zh) * 2020-04-14 2021-03-09 石河子大学 一种吲哚类化合物及其制备方法、应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US6057340A (en) * 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
DK1086101T3 (da) 1998-06-12 2003-03-31 Sod Conseils Rech Applic Beta-carbolinforbindelser

Also Published As

Publication number Publication date
PT1377578E (pt) 2011-09-23
MY134026A (en) 2007-11-30
HUP0400317A3 (en) 2007-10-29
BR0208566A (pt) 2004-03-30
ES2368389T3 (es) 2011-11-16
NO20034413L (no) 2003-10-02
RU2003130644A (ru) 2005-04-10
IL157545A0 (en) 2004-03-28
GB0108337D0 (en) 2001-05-23
NZ528370A (en) 2005-10-28
ZA200306108B (en) 2004-07-05
US20040132735A1 (en) 2004-07-08
WO2002081471A1 (en) 2002-10-17
PE20021018A1 (es) 2003-01-13
CZ20032655A3 (cs) 2003-12-17
EP1377578B1 (en) 2011-07-20
CN1309721C (zh) 2007-04-11
AU2002316828B2 (en) 2006-05-11
CZ295992B6 (cs) 2005-12-14
KR20040008150A (ko) 2004-01-28
ATE517104T1 (de) 2011-08-15
ECSP034754A (es) 2003-10-28
BR0208566B1 (pt) 2013-12-24
EP1377578A1 (en) 2004-01-07
SK12222003A3 (sk) 2004-06-08
CA2440014A1 (en) 2002-10-17
HUP0400317A2 (hu) 2004-09-28
NO20034413D0 (no) 2003-10-02
US6861430B2 (en) 2005-03-01
KR100564840B1 (ko) 2006-03-28
JP2004525178A (ja) 2004-08-19
CA2440014C (en) 2010-11-23
JP4405732B2 (ja) 2010-01-27
AR035451A1 (es) 2004-05-26
CN1500090A (zh) 2004-05-26
PL210861B1 (pl) 2012-03-30
PL362571A1 (en) 2004-11-02

Similar Documents

Publication Publication Date Title
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
MXPA03006775A (es) Formulacion farmaceutica.
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AUPQ969800A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
MXPA03007641A (es) Formulacion farmaceutica.
AU2002359126A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
MXPA03009057A (es) Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad.
AU2002359123A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
EP1379228A4 (en) (Z) -STYRYLBENZYLSULPONES AND THEIR PHARMACEUTICAL APPLICATIONS
EP1407771A4 (en) SOPHORIDINE AND ITS USE AS ANALYZIC
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
IL158266A0 (en) Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
HUP0402149A3 (en) Water-soluble phenylpyridazine derivatives, their use and pharmaceutical compositions containing the same
GB0128138D0 (en) Pharmaceutical use

Legal Events

Date Code Title Description
FG Grant or registration